Quellis Biosciences Competitors and Similar CompaniesClear all
Quellis Biosciences's competitors and similar companies include AiCuris, Anavex, Axsome Therapeutics and Eagle Pharmaceuticals.
 Quellis Biosciences Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases. |  AiCuris AiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents. |  Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases. |  Axsome Therapeutics Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system disorders. |  Eagle Pharmaceuticals Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas. | |
Founding Date | Founding Date 2017 | Founding Date 2006 | Founding Date 2006 | Founding Date 2012 | Founding Date 2007 |
Type | Type Subsidiary | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Wuppertal, DE HQ Borken, DE | Locations New York, US HQ Reno, US | Locations New York, US HQ New York, US | Locations Woodcliff Lake, US HQ Chicago, US |
Employees | Employees N/A | Employees 731% increase | Employees 1623% increase | Employees 4111% increase | Employees 10813% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 484.6 m | Valuation ($) 4.3 b | Valuation ($) 5.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $638.5m (FY, 2025) | Revenue (est.) $316.6m (FY, 2022) |
Net income | Net income N/A | Net income N/A | Net income ($46.4m) (FY, 2025) | Net income ($183.2m) (FY, 2025) | Net income $35.6m (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 17m | Total funding raised $ 74.8m | Total funding raised $ 12.6m | Total funding raised $ 7m | Total funding raised $ 12.3m |
For sources of this data, please see the company profile
View Company Profiles
AiCuris
HQ
Wuppertal, DE
Employees
73↑ 1% increase
AiCuris is a pharmaceutical company focusing on the discovery, research, and development of antiviral and antibacterial agents.
View companyAnavex
HQ
New York, US
Employees
16↑ 23% increase
Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
View companyAxsome Therapeutics
HQ
New York, US
Employees
41↑ 11% increase
Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for the management of central nervous system disorders.
View companyEagle Pharmaceuticals
HQ
Woodcliff Lake, US
Employees
108↑ 13% increase
Eagle Pharmaceuticals is a specialty pharmaceutical company, focusing on developing and commercializing injectable products primarily in the critical care and oncology areas.
View company